Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TIL Instil Bio, Inc.

休市中 12-05 16:00:00 EST

10.92

-0.47

-4.17%

盘后10.92

+0.000.00%

19:47 EST

最高11.44	最低10.76	成交量5.06万
今开11.34	昨收11.40	日振幅5.92%
总市值7,406万	流通市值3,612万	总股本678.20万
成交额55.88万	换手率1.53%	流通股本330.81万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TIL","market":"US","secType":"STK","nameCN":"Instil Bio, Inc.","latestPrice":10.92,"timestamp":1764968400000,"preClose":11.395,"halted":0,"volume":50582,"hourTrading":{"tag":"盘后","latestPrice":10.92,"preClose":10.92,"latestTime":"19:47 EST","volume":4,"amount":43.98,"timestamp":1764982056717},"delay":0,"floatShares":3308074,"shares":6781976,"eps":-11.368316,"marketStatus":"休市中","change":-0.475,"latestTime":"12-05 16:00:00 EST","open":11.34,"high":11.435,"low":10.76,"amount":558814.179707,"amplitude":0.059237,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.368316,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":11.395,"postHourTrading":{"tag":"盘后","latestPrice":10.92,"preClose":10.92,"latestTime":"19:47 EST","volume":4,"amount":43.98,"timestamp":1764982056717},"volumeRatio":0.8795554039439127,"impliedVol":5.6162,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TIL","defaultTab":"news","newsList":[{"id":"2581794293","title":"Instil Bio, Inc.盘中异动 股价大跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581794293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581794293?lang=zh_cn&edition=full","pubTime":"2025-11-05 03:47","pubTimestamp":1762285629,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日03时47分，Instil Bio, Inc.股票出现异动，股价大幅下挫5.79%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503470994ef2ffb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503470994ef2ffb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"gpt_icon":0},{"id":"2576094140","title":"Instil Bio, Inc.盘中异动 早盘大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576094140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576094140?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:33","pubTimestamp":1760711609,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日22时33分，Instil Bio, Inc.股票出现波动，股价快速下跌5.03%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017223329a6bf09ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017223329a6bf09ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2568171362","title":"Instil Bio, Inc.盘中异动 大幅下挫5.47%报19.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568171362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568171362?lang=zh_cn&edition=full","pubTime":"2025-09-20 01:58","pubTimestamp":1758304704,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日01时58分，Instil Bio, Inc.股票出现异动，股价急速下跌5.47%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920015825a72aa7c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920015825a72aa7c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2566695982","title":"Instil Bio, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566695982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566695982?lang=zh_cn&edition=full","pubTime":"2025-09-11 01:37","pubTimestamp":1757525844,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日01时37分，Instil Bio, Inc.股票出现波动，股价急速下挫5.22%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091101372497869596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091101372497869596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2557390424","title":"Instil Bio, Inc.盘中异动 大幅拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557390424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557390424?lang=zh_cn&edition=full","pubTime":"2025-08-05 22:35","pubTimestamp":1754404545,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日22时35分，Instil Bio, Inc.股票出现波动，股价快速拉升5.09%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.14%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805223546a6d4b52a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805223546a6d4b52a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2556338154","title":"Instil Bio, Inc.盘中异动 急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556338154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556338154?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:06","pubTimestamp":1754316399,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时06分，Instil Bio, Inc.股票出现波动，股价快速上涨5.11%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422064097330205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422064097330205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2556867397","title":"Instil Bio, Inc.7月31日成交额为996.76万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556867397","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556867397?lang=zh_cn&edition=full","pubTime":"2025-08-01 15:14","pubTimestamp":1754032477,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Instil Bio, Inc.成交额为996.76万美元，成交额较昨日增加170.41%，当日成交量为38.14万股。Instil Bio, Inc.于2025年7月31日跌11.14%，报24.0美元，该股过去5个交易日跌25.56%，年初至今涨25.72%，过去60日涨70.82%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-31|996.76万|170.41%|38.14万|#|2025-07-30|368.61万|-19.35%|13.06万|#|2025-07-29|457.03万|6.59%|16.26万|#|2025-07-28|428.79万|10.17%|14.18万|#|2025-07-25|389.22万|-43.26%|12.44万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801151445a46f2612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801151445a46f2612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2555013873","title":"Instil Bio, Inc.7月29日成交额为457.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555013873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555013873?lang=zh_cn&edition=full","pubTime":"2025-07-30 15:18","pubTimestamp":1753859912,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Instil Bio, Inc.成交额为457.03万美元，成交额较昨日增加6.59%，当日成交量为16.26万股。Instil Bio, Inc.于2025年7月29日跌4.78%，报28.27美元，该股过去5个交易日跌0.6%，年初至今涨48.09%，过去60日涨124.19%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-29|457.03万|6.59%|16.26万|#|2025-07-28|428.79万|10.17%|14.18万|#|2025-07-25|389.22万|-43.26%|12.44万|#|2025-07-24|686.01万|84.85%|22.00万|#|2025-07-23|371.11万|-12.43%|12.71万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730151926a46b0b4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730151926a46b0b4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2555807800","title":"Instil Bio, Inc.7月28日成交额为428.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555807800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555807800?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:13","pubTimestamp":1753773194,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Instil Bio, Inc.成交额为428.79万美元，成交额较昨日增加10.17%，当日成交量为14.18万股。Instil Bio, Inc.于2025年7月28日跌6.31%，报29.69美元，该股过去5个交易日涨7.49%，年初至今涨55.53%，过去60日涨131.05%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-28|428.79万|10.17%|14.18万|#|2025-07-25|389.22万|-43.26%|12.44万|#|2025-07-24|686.01万|84.85%|22.00万|#|2025-07-23|371.11万|-12.43%|12.71万|#|2025-07-22|423.81万|-14.46%|15.28万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729151322a6c74c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729151322a6c74c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2554708824","title":"Instil Bio, Inc.盘中异动 大幅下跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554708824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554708824?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:58","pubTimestamp":1753714726,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时58分，Instil Bio, Inc.股票出现异动，股价急速跳水5.30%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Abpro Holdings, Inc涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为399.81%、198.78%、118.86%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为117.26%、82.93%、75.48%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728225847a467f721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728225847a467f721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2554075904","title":"Instil Bio, Inc.7月24日成交额为686.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554075904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554075904?lang=zh_cn&edition=full","pubTime":"2025-07-25 14:47","pubTimestamp":1753426066,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，Instil Bio, Inc.成交额为686.01万美元，成交额较昨日增加84.85%，当日成交量为22.00万股。Instil Bio, Inc.于2025年7月24日涨8.66%，报32.24美元，该股过去5个交易日涨16.39%，年初至今涨68.88%，过去60日涨159.16%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-24|686.01万|84.85%|22.00万|#|2025-07-23|371.11万|-12.43%|12.71万|#|2025-07-22|423.81万|-14.46%|15.28万|#|2025-07-21|495.44万|16.43%|18.31万|#|2025-07-18|425.51万|-44.05%|15.93万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725144752a6c112c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725144752a6c112c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2552079105","title":"Instil Bio, Inc.7月16日成交额为740.16万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552079105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552079105?lang=zh_cn&edition=full","pubTime":"2025-07-17 14:40","pubTimestamp":1752734429,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，Instil Bio, Inc.成交额为740.16万美元，成交额较昨日增加47.46%，当日成交量为30.58万股。Instil Bio, Inc.于2025年7月16日涨7.58%，报25.68美元，该股过去5个交易日涨0.2%，年初至今涨34.52%，过去60日涨66.11%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-16|740.16万|47.46%|30.58万|#|2025-07-15|501.95万|13.51%|20.68万|#|2025-07-14|442.20万|14.12%|18.34万|#|2025-07-11|387.48万|-17.56%|15.67万|#|2025-07-10|470.03万|-40.28%|17.94万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717144039a45056e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717144039a45056e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2551193433","title":"Instil Bio, Inc.盘中异动 早盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551193433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551193433?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:37","pubTimestamp":1752586649,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时37分，Instil Bio, Inc.股票出现波动，股价急速上涨5.31%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Kairos Pharma, Ltd.、Polyrizon Ltd.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，60 Degrees Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.较为活跃，换手率分别为1347.88%、719.77%、402.37%，振幅较大的相关个股有Kairos Pharma, Ltd.、Polyrizon Ltd.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为40.87%、27.12%、21.10%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071521372995438a2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071521372995438a2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2551435193","title":"Instil Bio, Inc.7月14日成交额为442.20万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551435193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551435193?lang=zh_cn&edition=full","pubTime":"2025-07-15 14:56","pubTimestamp":1752562613,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，Instil Bio, Inc.成交额为442.20万美元，成交额较昨日增加14.12%，当日成交量为18.34万股。Instil Bio, Inc.于2025年7月14日涨0.0%，报24.49美元，该股过去5个交易日涨3.6%，年初至今涨28.29%，过去60日涨48.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-14|442.20万|14.12%|18.34万|#|2025-07-11|387.48万|-17.56%|15.67万|#|2025-07-10|470.03万|-40.28%|17.94万|#|2025-07-09|786.99万|52.03%|30.93万|#|2025-07-08|517.65万|-67.62%|22.10万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715145658a44b9de5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715145658a44b9de5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2550981395","title":"Instil Bio, Inc.7月10日成交额为470.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550981395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550981395?lang=zh_cn&edition=full","pubTime":"2025-07-11 14:57","pubTimestamp":1752217051,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，Instil Bio, Inc.成交额为470.03万美元，成交额较昨日减少40.28%，当日成交量为17.94万股。Instil Bio, Inc.于2025年7月10日涨4.41%，报26.76美元，该股过去5个交易日涨12.39%，年初至今涨40.18%，过去60日涨78.04%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-10|470.03万|-40.28%|17.94万|#|2025-07-09|786.99万|52.03%|30.93万|#|2025-07-08|517.65万|-67.62%|22.10万|#|2025-07-07|1598.46万|-3.34%|67.65万|#|2025-07-03|1653.73万|112.51%|59.66万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711145736a44422bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711145736a44422bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2550561335","title":"Instil Bio, Inc.7月9日成交额为786.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550561335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550561335?lang=zh_cn&edition=full","pubTime":"2025-07-10 14:49","pubTimestamp":1752130151,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Instil Bio, Inc.成交额为786.99万美元，成交额较昨日增加52.03%，当日成交量为30.93万股。Instil Bio, Inc.于2025年7月9日涨9.39%，报25.63美元，该股过去5个交易日涨16.87%，年初至今涨34.26%，过去60日涨80.75%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-09|786.99万|52.03%|30.93万|#|2025-07-08|517.65万|-67.62%|22.10万|#|2025-07-07|1598.46万|-3.34%|67.65万|#|2025-07-03|1653.73万|112.51%|59.66万|#|2025-07-02|778.19万|16.30%|32.00万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710144916a441e5cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710144916a441e5cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"gpt_icon":0},{"id":"2550683217","title":"Instil Bio, Inc.7月8日成交额为517.65万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550683217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550683217?lang=zh_cn&edition=full","pubTime":"2025-07-09 14:44","pubTimestamp":1752043498,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Instil Bio, Inc.成交额为517.65万美元，成交额较昨日减少67.62%，当日成交量为22.10万股。Instil Bio, Inc.于2025年7月8日跌0.89%，报23.43美元，该股过去5个交易日涨12.48%，年初至今涨22.73%，过去60日涨54.96%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-08|517.65万|-67.62%|22.10万|#|2025-07-07|1598.46万|-3.34%|67.65万|#|2025-07-03|1653.73万|112.51%|59.66万|#|2025-07-02|778.19万|16.30%|32.00万|#|2025-07-01|669.15万|16.90%|30.65万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709144500a69ebc1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709144500a69ebc1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2549604518","title":"Instil Bio, Inc.7月7日成交额为1598.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549604518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549604518?lang=zh_cn&edition=full","pubTime":"2025-07-08 14:34","pubTimestamp":1751956464,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Instil Bio, Inc.成交额为1598.46万美元，成交额较昨日减少3.34%，当日成交量为67.65万股。Instil Bio, Inc.于2025年7月7日跌14.04%，报23.64美元，该股过去5个交易日涨2.92%，年初至今涨23.83%，过去60日涨73.95%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-07|1598.46万|-3.34%|67.65万|#|2025-07-03|1653.73万|112.51%|59.66万|#|2025-07-02|778.19万|16.30%|32.00万|#|2025-07-01|669.15万|16.90%|30.65万|#|2025-06-30|572.40万|-13.52%|26.26万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708143430a69c7bd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708143430a69c7bd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2548271278","title":"Instil Bio, Inc.7月2日成交额为778.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548271278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548271278?lang=zh_cn&edition=full","pubTime":"2025-07-03 14:31","pubTimestamp":1751524285,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Instil Bio, Inc.成交额为778.19万美元，成交额较昨日增加16.30%，当日成交量为32.00万股。Instil Bio, Inc.于2025年7月2日涨8.57%，报23.81美元，该股过去5个交易日跌11.52%，年初至今涨24.72%，过去60日涨62.97%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-02|778.19万|16.30%|32.00万|#|2025-07-01|669.15万|16.90%|30.65万|#|2025-06-30|572.40万|-13.52%|26.26万|#|2025-06-27|661.91万|-50.40%|29.41万|#|2025-06-26|1334.37万|60.94%|56.80万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703143134a72c0b22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703143134a72c0b22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2548085796","title":"Instil Bio, Inc.7月1日成交额为669.15万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548085796","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548085796?lang=zh_cn&edition=full","pubTime":"2025-07-02 14:17","pubTimestamp":1751437068,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Instil Bio, Inc.成交额为669.15万美元，成交额较昨日增加16.90%，当日成交量为30.65万股。Instil Bio, Inc.于2025年7月1日涨5.28%，报21.93美元，该股过去5个交易日跌23.13%，年初至今涨14.88%，过去60日涨31.87%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-01|669.15万|16.90%|30.65万|#|2025-06-30|572.40万|-13.52%|26.26万|#|2025-06-27|661.91万|-50.40%|29.41万|#|2025-06-26|1334.37万|60.94%|56.80万|#|2025-06-25|829.13万|33.66%|29.86万|Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发用于治疗癌症患者的自体肿瘤浸润性淋巴细胞的细胞治疗管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702141756a4ca7853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702141756a4ca7853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0}],"profile":{"websiteUrl":"https://instilbio.com/","stockEarnings":[{"period":"1week","weight":-0.1442},{"period":"1month","weight":-0.2927},{"period":"3month","weight":-0.6533},{"period":"6month","weight":-0.668},{"period":"1year","weight":-0.583},{"period":"ytd","weight":-0.428}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Instil Bio, Inc.总部位于德克萨斯州达拉斯，于2018年8月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，致力于开发创新的自体肿瘤浸润淋巴细胞（TIL）治疗细胞疗法，以治疗癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.171267},{"month":2,"riseRate":0.25,"avgChangeRate":-0.051969},{"month":3,"riseRate":0.25,"avgChangeRate":-0.094518},{"month":4,"riseRate":0.2,"avgChangeRate":-0.158547},{"month":5,"riseRate":0.2,"avgChangeRate":0.143926},{"month":6,"riseRate":0.2,"avgChangeRate":-0.098253},{"month":7,"riseRate":0.6,"avgChangeRate":0.06531},{"month":8,"riseRate":0.6,"avgChangeRate":0.054198},{"month":9,"riseRate":0.2,"avgChangeRate":0.663025},{"month":10,"riseRate":0.2,"avgChangeRate":-0.170435},{"month":11,"riseRate":0.2,"avgChangeRate":-0.206869},{"month":12,"riseRate":0.2,"avgChangeRate":-0.211625}],"exchange":"NASDAQ","name":"Instil Bio, Inc.","nameEN":"Instil Bio, Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Instil Bio, Inc.,TIL,Instil Bio, Inc.股票,Instil Bio, Inc.股票老虎,Instil Bio, Inc.股票老虎国际,Instil Bio, Inc.行情,Instil Bio, Inc.股票行情,Instil Bio, Inc.股价,Instil Bio, Inc.股市,Instil Bio, Inc.股票价格,Instil Bio, Inc.股票交易,Instil Bio, Inc.股票购买,Instil Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}